Molecular Imaging: Page 69

PET superior to MRI for meningioma treatment planning

By Will Morton

PET imaging with a gallium-68 (Ga-68)-based radiotracer is more precise than standard MRI for detecting meningiomas targeted for radiotherapy, according to a study published April 20 in the International Journal of Radiation, Oncology, Biology, Physics.

April 24, 2022

Brain PET algorithm shows promise in diagnosing Parkinson's disease

By AuntMinnie.com staff writers

Researchers have developed an artificial intelligence (AI) deep-learning algorithm that may help clinicians diagnose parkinsonian diseases, according to research published in the April issue of the Journal of Nuclear Medicine.

April 21, 2022

Midtherapy PET/CT predicts response in patients with esophageal cancer

By Will Morton

Performing PET/CT scans while patients are undergoing radiotherapy prior to surgery for esophageal cancer can help predict whether they will respond to treatment, according to a study published April 18 in Radiotherapy and Oncology.

April 21, 2022

Clarity treats first patient in COBRA trial

By AuntMinnie.com staff writers

Australian-based radiopharmaceutical developer Clarity Pharmaceuticals has treated the first U.S. patient in a trial of its new copper-64-based PSMA imaging radiotracer for prostate cancer.

April 20, 2022

Dual-tracer PET/CT shows promise in cancer imaging

By Will Morton

Two PET/CT radiotracers -- F-18 FDG and gallium-68 FAPI-46 -- work better together than when used alone for cancer imaging, according to a proof-of-concept study published April 14 in the Journal of Nuclear Medicine.

April 19, 2022

Tau PET reveals patterns of early Alzheimer's disease

By Will Morton

PET scans in patients with early Alzheimer's disease reveal patterns of tau deposits that could help researchers improve the selection of at-risk patients for new drug trials, according to a study published April 18 in JAMA Neurology.

April 18, 2022

Navidea secures Indian regulatory approval for Lymphoseek

By AuntMinnie.com staff writers

Navidea Biopharmaceuticals has secured regulatory approval from India's Central Drugs Standard Control Organization for its technetium-99m tilmanocept radiopharmaceutical Lymphoseek.

April 17, 2022

Shine appoints two new board members

By AuntMinnie.com staff writers

Medical isotope company Shine Technologies has appointed Holli Ladhani and Janet Wong to the company's board of directors.

April 13, 2022

Telix touts rollout of Illuccix PSMA-PET radiotracer

By AuntMinnie.com staff writers

Telix Pharmaceuticals said its prostate-specific membrane antigen PET radiopharmaceutical Illuccix is now available to order from 117 pharmacies in the Telix network.

April 13, 2022

ITM, MTTI ink lutetium-177 supply deal

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich's subsidiary ITM Medical Isotopes and biopharmaceutical company Molecular Targeting Technologies (MTTI) have signed a supply deal for no-carrier-added lutetium-177.

April 12, 2022

NYSE accepts Navidea bid to comply with stock listing rules

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals said the New York Stock Exchange (NYSE) has accepted its plan to regain compliance with the stock exchange's listing requirements. Navidea now has until July 28, 2023, to regain compliance.

April 12, 2022

PET predicts chemotherapy response in cancer patients

By Will Morton

PET imaging can help predict whether patients will respond to chemotherapy for pancreatic cancer before surgery, according to a study published April 8 in Clinical Radiology.

April 12, 2022

Previous Page

Page 69 of 611

Next Page